Stage IIA Prostate Cancer Withdrawn Phase Trials for Atorvastatin (DB01076)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01555632Atorvastatin Calcium in Preventing Metabolic Syndrome in Patients With Prostate Cancer Receiving Long-Term Androgen-Deprivation TherapyTreatment